Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3751_Библиотеки_им_академика_М_И_Перельмана
.pdf
surgicalemergencies,338,338
Linearnonthresholdmodel,6
Lowerextremityintervention,11
Lowerextremity,stenttherapies
balloon-expandablecoveredstents
vs.bare-metalstents(BMS),261,263
principles,261
TASCCandDlesions,263
bare-metalballoon-expandablestents
commoniliacartery,260–261,262t
principles,260
bioresorbablescaffolds
clinicaltrials,272
principles,271
drug-elutingself-expandingstents,269–271,271t
history,260
self-expandingbare-metalstentsSeeSelf-expandingstents
self-expandingcoveredstents
antiplatelet/antithrombotictherapy,267
peripheralarterialdisease(PAD),266–267
principles,264,266
Viabahnstentgrafts,267,268t
technology,260
Low-osmolarmonomeriohexol(Omnipaque),4,9
Low-pressureballoonangioplasty,162
LVOsSeeLargevesselocclusions(LVOs)
M
Magneticresonanceangiography(MRA)
aortoiliacocclusivedisease(AIOD),201
carotidarterystenosis
contrast,36
high-resolutionimagingalgorithms,38
noncontrast,36
time-of-flight(TOF)imaging,36,39
time-resolvedMRAtechniques,38
descendingaorta,endovascularrepair,141
renovasculardisease,181
subclavianarterystenosis/interventions,68
Magneticresonanceimaging(MRI),20
ascendingaortaandaorticarch,111–112
Magneticresonancevenography(MRV)
May-Thurnersyndrome(MTS),384
venousthromboembolism(VTE),374
https://t.me/med1917

Marfanoidaneurysm,103
May-Thurnersyndrome(MTS)
balloonangioplastyandstenting,391
clinicalhistory,382
colordopplerultrasound(CDUS),383
contrastvenography,384
CTimaging,384
anddeepveinthrombosis(DVT),381
differentialdiagnosis,382–383
duplexultrasound(DUS),383
history,380
iliacveincompressionsyndrome,380–381
acutedeepveinthrombosis,388–389
withpostthromboticsyndrome(PTS),390
withsymptomaticnonthromboticchronicvenousinsufficiency,390
iliacveinthrombosis,380
intravascularultrasound(IVUS),384–385
magneticresonancevenography(MRV),384
noninvasivetreatment
endovenoustreatmentoptions,386–388
surgicalmanagement,386
therapeuticanticoagulation,385
pathophysiology,381
physicalexamination,382
postthromboticsyndrome(PTS),380
prevalence,380
recurrentstenosis,392
shareddecision-making,391
MechanicalRetrievalandRecanalizationofStrokeClotsUsingEmbolectomy(MRRESCUE),23
Mechanochemicalablation(MOCA)
ClariVeindevice,400
vs.RadiofrequencyAblation,401
MedtronicArchBranchdevice,115–116
MedtronicClosureFastdevice,398–399,399
MedtronicSilverHawkandTurboHawk,284,285
Mesentericarterystenosis,12
Metallicoralimplants,36
Metrizamide(Amipaque),3
Micropuncturetechnique,54–55
Minimallyinvasivetherapy,2
MOCASeeMechanochemicalablation(MOCA)
MountedCPCoveredStent,88
MRASeeMagneticresonanceangiography(MRA)
MRISeeMagneticresonanceimaging(MRI)
https://t.me/med1917

MRRESCUESeeMechanicalRetrievalandRecanalizationofStrokeClotsUsingEmbolectomy(MRRESCUE)
MRVSeeMagneticresonancevenography(MRV)
MTSSeeMay-Thurnersyndrome(MTS)
MulticenterRandomizedClinicalTrialofEndovascularTreatmentforAcuteIschemicStrokeintheNetherlands(MRCLEAN),23
N
Najutaendograftsystem,116
NASCETSeeNorthAmericanSymptomaticCarotidEndarterectomyTrial(NASCET)
NationalInstituteofHealthStrokeScale,11
NationalInstituteofNeurologicalDisordersandStroke(NINDS),20
Negativepressurewoundtherapy(NPWT),340
NINDSSeeNationalInstituteofNeurologicalDisordersandStroke(NINDS)
Nonatheroscleroticrenovasculardisease
fibromusculardysplasia,178–179,179–180
posttransplantrenalvasculopathy,179
renalarterythromboembolization,179
Noncontrastcomputedtomography(NCCT),20
Nonioniccontrasts,9
NorthAmericanSymptomaticCarotidEndarterectomyTrial(NASCET),43,46
No-touchtechnique,endoluminalstenting,184–185
NuMEDCPstent,87
O
Occlusiveperipheralarterialdisease,298
ONTARGETtrial,322
Oralanticoagulation,375
Oralanticoagulationagents,321
Orbitalatherectomy(OA),282t
above-the-kneePAD,283
CALCIUM360study,283
Diamondback360,282,283
Osteomyelitis
dressingoptions,339
negativepressurewoundtherapy(NPWT),340
sharpdebridement,339
ulcerativesites,339
vascularassessment,340
Outbackcatheter,205
Outbackre-entrycatheter,292,293
P
PACIFIERtrial,250,251–252
Paclitaxel-coatedballoonvs.uncoatedballoonangioplasty,250,251
PADSeePeripheralarterialdisease(PAD)
https://t.me/med1917

PAHSeePulmonaryarterialhypertension(PAH)
PalmazXL10seriesstent,85–86
PARADISEtrial,249
Parallelstenttechnique,114–115
Patientselection
abdominalaorticaneurysms,12
acuteischemicstroke,11
carotidarterystenosis,11
deepvenousthrombosis,12
diagnosis,11
lowerextremityintervention,11
mesentericarterystenosis,12
physicalexamination,11
renalarterystenosis,12
upperextremityintervention,11
PAUSeePenetratingaorticulcer(PAU)
Pedalangiography,8
Penetratingaorticulcer(PAU),107,107
Penumbra,19–20
Percuataneousultrasonography-assistedfibrinolysis,306
Percutaneousaspirationthrombectomy,306
Percutaneousmechanicalthrombectomy(PMT),305
Percutaneoustransluminalangioplasty(PTA),214,218–219,245
clinicaltrials,221–223,222t
drug-coatedballoons(DCB),223–224
drug-elutingstents(DES),223
UnitedStatesFoodandDrugAdministration(FDA),223–224
Peripheralarterialaccesstechnique,51
Peripheralarterialdisease(PAD),244–245
acutelimbischemia(ALI),298–299
atherectomy
directionalSeeDirectionalatherectomy(DA)
excimerlaseratherectomy(ELA)SeeExcimerlaseratherectomy(ELA)
orbitalSeeOrbitalatherectomy(OA)
percutaneousinterventions,276
phoenixatherectomydeviceSeePhoenixatherectomydevice
principles,276–277
rotationalSeeRotationalatherectomy(RA)
treatment,276
ZilverPTXDES,276
catheter-basedinterventions,217
claudication,215
criticallimbischemia(CLI),215
lesioncrossing,220–221
https://t.me/med1917

medicaltherapy
exerciseprograms,216
pharmacotherapy,216–217
smokingcessation,217
patientsatrisk,215
percutaneoustransluminalangioplasty(PTA),218–219
pharmacotherapy
antihypertensivetherapy,322
antithrombotictherapySeeAntithrombotictherapy
claudication,symptomatictherapy,322–323
guideline-directedmedicaltherapy(GDMT),318
medicalmanagement,318
statins,321–322
physicalexamination,abnormal,215–216
revascularization,216
SocietyforVascularSurgery(SVS)guidelines,217–218,218t
Trans-AtlanticInter-SocietyConsensusdocumentII(TASCII),218,218t
vascularaccess,219–220,219t
Peripheralvascularangiography,8–9
PHSeePulmonaryhypertension(PH)
Phoenixatherectomydevice,285t
EndovascularAtherectomySafetyandEffectivenessStudy(EASE)trial,286
byRoyalPhilips,285,286
PhotoablationUsingtheTurbo-BoosterandExcimerLaserforIn-StentRestenosisTreatment(PATENT)study,279
Pioneercatheter,205,205
Pioneerpluscatheter,290
intravascularultrasound(IVUS),291,292
byPhilips-VolcanoCorporation,291,291
TransVascularSystems,291
Plateletrecruitment,375
PMTSeePercutaneousmechanicalthrombectomy(PMT)
Polytetrafluoroethylene(PTFE)-coveredstents,225
PoPHSeePortopulmonaryhypertension(PoPH)
Portopulmonaryhypertension(PoPH),360
Postthromboticsyndrome(PTS),368,380,390
Posttransplantrenalvasculopathy,nonatheroscleroticrenovasculardisease,179
PROACTtrialSeeProlyseinAcuteCerebralThromboembolism(PROACT)trial
Progradecatheter,84,91–92
ProlyseinAcuteCerebralThromboembolism(PROACT)trial,21
Pseudoaneurysms(PSAs)
arterialwallrupture,330
diagnosis,330–331,331
incidence,330
management,331–332
https://t.me/med1917

riskfactors,330
PTASeePercutaneoustransluminalangioplasty(PTA)
PTFE-coveredstentsSeePolytetrafluoroethylene(PTFE)-coveredstents
PTSSeePostthromboticsyndrome(PTS)
Pulmonaryarterialhypertension(PAH)
clinicalpresentation,355
diagnosis,355–356
palliativeatrialseptostomy,360
prevalence,355
treatment,356–357
Pulmonaryarterystenosis
balloonangioplastySeeBalloonangioplasty
cuttingballoonangioplasty,163–164
etiology,158–159,159t,160–162
goalsof,161
interventionsindications,160
intrinsicandextrinsicfactors,158
managementstrategies,158
pathophysiology,159
patient-specificstrategies,158
stent
angioplasty,165–166,165
selection,166–169,167t
therapeuticalgorithms,169,170
Pulmonarycongestion,renovasculardisease,175–176
Pulmonaryendarterectomy,361–362
Pulmonaryhypertension(PH)
atrialseptaldefects(ASDs)SeeAtrialseptaldefects(ASDs)
chronicthromboembolicpulmonaryhypertension(CTEPH)SeeChronicthromboembolicpulmonaryhypertension(CTEPH)
definition,354–355
epidemiology,355
portopulmonaryhypertension(PoPH),360
pulmonaryarterialhypertension(PAH)SeePulmonaryarterialhypertension(PAH)
Pulmonaryvasculardisease(PVD)
acutepulmonaryembolism(PE)SeeAcutepulmonaryembolism(PE)
conditions,349
pulmonaryhypertension(PH)SeePulmonaryhypertension(PH)
PURPOSEtrial,303
PVDSeePulmonaryvasculardisease(PVD)
Q
Quantitativeangiography,9
R
https://t.me/med1917

RASeeRotationalatherectomy(RA)
Radialhemorrhage,328
Radiofrequencyablation
complications,399
endothemalheat–inducedthrombosis(EHIT),399,400
vs.endovenouslaserablation,404
MedtronicClosureFastdevice,398–399,399
VNUSClosureSystem,398
RandomizedStudyComparingtheEdwardsSelf-ExpandingLifeStentversusAngioplasty-aloneInLesionsInvolvingtheSFAand/orProximal
PoplitealArtery(RESILIENT)study,225
RandomizedTrialofRevascularizationwithSolitaireFRDeviceversusBestMedicalTherapyintheTreatmentofAcuteStrokeDueto
AnteriorCirculationLargeVesselOcclusionPresentingwithin8hoursofSymptomOnset(REVASCAT)trial,24
Recurrentvenousthromboembolism,368
Reentrydevices
chronictotalocclusions(CTO),290
Outbackre-entrycatheter,292,293
Pioneerpluscatheter,290
intravascularultrasound(IVUS),291,292
byPhilips-VolcanoCorporation,291,291
TransVascularSystems,291
Relaythoracicstent-graftsystem,135–136,135
Renalarterystenosis,12SeeRenovasculardisease
Renalarterythromboembolization,nonatheroscleroticrenovasculardisease,179
Renalsympatheticdenervation
extrarenalcirculatorydisorders,192–193,192t
resistanthypertension
catheter-baseddenervation,189–190
earlysurgery,189
prevalence,189
SPYRALHTN-OFFMEDtrial,192
SymplicityHTN-1Study,190
SymplicityHTN-2Trial,191
SymplicityHTN-3Trial,191–192
Renalveinthrombosis,189
Renovasculardisease
anatomicconsiderations,175
atheroscleroticrenovasculardiseaseSeeAtheroscleroticrenovasculardisease
catheter-basedtechniques,175
ClassIIaindication,193
ClassIIbindication,194
ClassIindication,193
clinicalpresentations
clinicalindicators,177,177t
medicalliterature,176–177
population,177
https://t.me/med1917

diagnosticexaminations
atheroscleroticrenalarterystenosis,182–183,182
captoprilrenalarteryscintigraphy,181
CTangiography,181
duplexultrasound(DUS),180–181
invasiverenalveinsampling,181
MRangiography,181
percutaneousrenalangiography,181–182
interventionaltherapies,193,193t
laterenalischemiaanddysfunction,176
medicalvs.transcathetermanagement
AngioplastyandStentingforRenalArteryLesions(ASTRALTrial),187–188
CardiovascularOutcomesinRenalAtheroscleroticLesions(CORAL)trial,188
DutchRenalArteryStenosisInterventionCooperativeStudytrial(DRASTIC),187
EssaiMulticentriqueMedicamentsvsAngioplastie(EMMA)study,187
meta-analysis,187
ScottishandNewcastleRenalArteryStenosisCollaborativeGroup,187
StentPlacementinPatientswithAtheroscleroticRenalArteryStenosisandImpairedRenalFunction(STARTrial),187
nonatheroscleroticrenovasculardisease
fibromusculardysplasia,178–179,179–180
posttransplantrenalvasculopathy,179
renalarterythromboembolization,179
pulmonarycongestion,175–176
renalsympatheticdenervationSeeRenalsympatheticdenervation
renalveinthrombosis,189
revascularization
balloonangioplasty,184
earlysurgicalmethods,183
endoluminalstentingSeeEndoluminalstenting
systemichypertension,175
Reperfusioninjury,306–307
Retrogradewireadvancementtechnique,205
Retroperitoneal(RP)hemorrhage,327–328,328
Rheolyticthrombectomy,352
Rhomboidtranspositionalflap,342,342
Rotationalatherectomy(RA),280t
infrainguinalPAD,280–282
JetstreamXC,280,281
Rotationalthrombectomy,353
Rutherfordclassification,301
S
Sclerotherapy,400
liquid/foamapplication,401
https://t.me/med1917

withultrasoundguidance,401
varicoseveins,401
Varithena,402
Scoringballoonsangioplasty,239
ScottishandNewcastleRenalArteryStenosisCollaborativeGroup,187
Self-expandingstents
bare-metalstents(BMS),264,265t
nitinol,264peipheralstents,267–268strutfracture,267–268Superastent,268–269
Wallstent,263
coveredstents
antiplatelet/antithrombotictherapy,267
peripheralarterialdisease(PAD),266–267
principles,264,266
Viabahnstentgrafts,267,268t
drug-elutingstents(DES)
first-generation,269
in-development,270–271
paclitaxelperipheral,270,271t
SFAdiseaseSeeSuperficialfemoralartery(SFA)disease
SIROCCOIandIItrial,246–247
SirolimusCoatedCordisSmartNitinolSelf-expandableStentfortheSuperficialFemoralArteryDisease(SIROCCO)randomizedtrial,225
SMFMSeeStreamlinerMultilayerFlowModulator(SMFM)
Smokingcessation,217
Snorkel/chimneytechniqueSeeParallelstenttechnique
SocietyforVascularSurgery(SVS)guidelines,217–218,218t
SolitairewiththeIntentionforThrombec-tomyasPrimaryEndovascularTreatmentforAcuteIschemicStroke(SWIFTPRIME),24
Splitthicknessskingrafting(STSG),341,341
SPYRALHTN-OFFMEDtrial,192
Statins
hyperlipidemia,321
trials,321–322
venousthromboembolism(VTE)
JupiterTrial,374
oralanticoagulation,375
plateletrecruitment,375
therapy,375
Stentangioplasty
aorticcoarctation
aneurysmformationrates,85
balloonselection,90
BIBcatheter,88
CheathamPlatinum(CP)Stent,85
compliance,91
complications,92–93
https://t.me/med1917

CoveredCPStent,85
equipment,87
hand-crimping,90–91
large-diametercoveredstents,88
multi-institutionalregistrystudy,85
NuMEDBIBballoon,91
polytetrafluoroethylene(PFTE),91
postimplantdilation,88
progradecatheter,91–92
requirements,89
selection,85–87,89–90,90t
sheaths,88
wires,88
pulmonaryarterystenosis,165–166,165
Stenting
aortoiliacocclusivedisease(AIOD)
aorticbifurcationlesions,207
aortoiliaclesions,207
bilateralcommoniliacarteries,207
commoniliacarteries,206
descendingaortalesions,206
DutchIliacStentTrial,206
endovascularinterventions,206
infrarenalaortalesions,206
isolatedaorticlesions,207
isolatedostialiliaclesions,207
occlusions,207
proximalcommoniliaclesions,207
TASCAandBlesions,206
baremetalstents(BMS),224–225
drug-elutingstents(DES),225–226
May-Thurnersyndrome(MTS),391
polytetrafluoroethylene(PTFE)-coveredstents,225
StentingandAggressiveMedicalManagementforPreventingRecurrentstrokeinIntracranialStenosis(SAMMPRIS)Study,48–49
StentingandAngioplastywithProtectioninPatientswithHighRiskofEndarterectomy(SAPPHIRE)trial,45
StentPlacementinPatientswithAtheroscleroticRenalArteryStenosisandImpairedRenalFunction(STARTrial),187
Stentthrombosis,aortoiliacocclusivedisease(AIOD),209
StreamlinerMultilayerFlowModulator(SMFM),140,140
Stroke
descendingaorta,endovascularrepair,148
syndromes,21
STSGSeeSplitthicknessskingrafting(STSG)
Subclavianangiography,7
Subclavianarterystenosis
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана
